Trial Details

TERMINATED
Basic Information
Clinical ID c4623
Identifier NCT00245505
Trial Title The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active Drug: Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: Mesalazine (Mesalamine)
Participant Information
Sponsor Ferring Pharmaceuticals
City Malmö
Country/Region Sweden
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2009-02
Primary Completion Date 2009-06
Completion Date 2009-07